Patents Assigned to Reneuron, Inc.
  • Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture
    Patent number: 9745554
    Abstract: The invention relates to the discovery that the proliferation and survival of pancreatic progenitor cells can be enhanced by contacting the cells with, (1) a caspase inhibitor sufficient to reduce apoptosis in the pancreatic endocrine cells; and, (2) a growth factor in an amount sufficient to increase the level of activated Akt in the pancreatic endocrine cells.
    Type: Grant
    Filed: January 18, 2007
    Date of Patent: August 29, 2017
    Assignee: ReNeuron, Inc.
    Inventors: Monica Florio, Aleksandar Francki, Wen-Ghih Tsang
  • CD56 positive human adult pancreatic endocrine progenitor cells
    Patent number: 9068169
    Abstract: The invention relates to the discovery of a selective cell surface marker that permits the selection of a unique subset of pancreatic stems cells having a high propensity to differentiate into insulin producing cells or into insulin producing cell aggregates.
    Type: Grant
    Filed: May 2, 2008
    Date of Patent: June 30, 2015
    Assignee: RENEURON, INC.
    Inventors: Wen-Ghih Tsang, Tianli Zheng, Wei Liu
  • EPHA4-positive human adult pancreatic endocrine progenitor cells
    Patent number: 8377689
    Abstract: The invention relates to the discovery of a selective cell surface marker that permits the selection of a unique subset of pancreatic stem cells having a high propensity to differentiate into insulin-producing cells or into insulin-producing cell aggregates.
    Type: Grant
    Filed: September 24, 2010
    Date of Patent: February 19, 2013
    Assignee: ReNeuron, Inc.
    Inventors: Wen-Ghih Tsang, Yanping Wang, Jinghua Tang
  • METHOD OF IMPROVING CELL PROLIFERATION OF PANCREATIC PROGENITOR CELLS IN A PANCREATIC CELL CULTURE
    Publication number: 20100311166
    Abstract: The invention relates to the discovery that the proliferation and survival of pancreatic progenitor cells can be enhanced by contacting the cells with, (1) a caspase inhibitor sufficient to reduce apoptosis in the pancreatic endocrine cells; and, (2) a growth factor in an amount sufficient to increase the level of activated Akt in the pancreatic endocrine cells.
    Type: Application
    Filed: January 18, 2007
    Publication date: December 9, 2010
    Applicant: ReNeuron, Inc.
    Inventors: Monica Florio, Aleksandar Francki, Wen-Ghih Tsang
  • EphA4-positive human adult pancreatic endocrine progenitor cells
    Patent number: 7807459
    Abstract: The invention relates to the discovery of a selective cell surface marker that permits the selection of a unique subset of pancreatic stem cells having a high propensity to differentiate into insulin-producing cells or into insulin-producing cell aggregates.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: October 5, 2010
    Assignee: ReNeuron, Inc.
    Inventors: Wen-Ghih Tsang, Yanping Wang, Jinghua Tang
  • CD56 POSITIVE HUMAN ADULT PANCREATIC ENDOCRINE PROGENITOR CELLS
    Publication number: 20090246178
    Abstract: The invention relates to the discovery of a selective cell surface marker that permits the selection of a unique subset of pancreatic stems cells having a high propensity to differentiate into insulin producing cells or into insulin producing cell aggregates.
    Type: Application
    Filed: May 2, 2008
    Publication date: October 1, 2009
    Applicant: RENEURON, INC.
    Inventors: WEN-GHIH TSANG, TIANLI ZHENG, WEI LIU
  • CD56 positive human adult pancreatic endocrine progenitor cells
    Patent number: 7371576
    Abstract: The invention relates to the discovery of a selective cell surface marker that permits the selection of a unique subset of pancreatic stems cells having a high propensity to differentiate into insulin producing cells or into insulin producing cell aggregates.
    Type: Grant
    Filed: September 8, 2003
    Date of Patent: May 13, 2008
    Assignee: Reneuron, Inc.
    Inventors: Wen-Ghih Tsang, Tianli Zheng, Wei Liu